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The in vitro susceptibility of penicillinase-producing and intrinsically resistant
Neisseria gonorrhoeae strains to 13 antimicrobial agents was tested. Regardless
of the type of resistance, these organisms remained quite susceptible to newer
cephalosporin agents, including moxalactam, cefoperazone, cefotaxime, and
ceftazidime.
In recent years, many strains of Neisseria
gonorrhoeae have demonstrated increased
resistance to penicillin (1-6, 8, 9, 11-17). Resist-
ance to penicillin occurs either because of pro-
duction of beta-lactamase (penicillinase) or as a
result of intrinsic resistance. The latter may
reflect an alteration in one or more penicillin-
binding proteins (5, 14) or a decrease in the
permeability of the outer membrane to antibiot-
ics (7). The clinical importance of these observa-
tions has prompted a search for safe and effec-
tive antibiotic agents. The present study was
initiated to compare the activities of 'several
newer antibiotics against both beta-lactamase-
positive and -negative penicillin-resistant N.
gonorrhoeae strains.
The antimicrobial agents employed were do-
nated by or purchased from The Upjohn Co.,
Kalamazoo, Mich. (spectinomycin); Bristol
Laboratories, Syracuse, N.Y. (ampicillin and
kanamycin); Nutritional Biochemicals Corp.,
Cleveland, Ohio (tetracycline); Pfizer, Inc.,
New York, N.Y. (cefoperazone); Hoechst-
Roussel Pharmaceuticals, Inc., Somerville, N.J.
(cefotaxime); Eli Lilly & Co., Indianapolis, Ind.
'(moxalactam, cephalexin, and penicillin G);
Schering Corp., Bloomfield, N.J. (penem, Sch
29,482); and Glaxo Group, Research Triangle
Park, N.C. (ceftazidime).
A total of 53 strains of N. gonorrhoeae were
tested. Thirty-one strains were collected from
patients with anogenital infections in North Car-
olina. Among this group, four were beta-lacta-
mase positive as determined by the method of
O'Callaghan et al. (10). Nineteen penicillin-re-
sistant isolates, six of which were beta-lacta-
mase positive, were provided by T. Tupasi,
University of the Philippines, Manila. The other
13 strains from the Philippines demonstrated
intrinsic resistance to penicillin (minimal inhibi-
tory concentration [MIC], >0.5 jig/ml, beta lac-
tamase negative), as did 3 strains donated by I.
Lind, Statens Seruminstitut, Copenhagen.
The identity of all isolates was confirmed by
growth on gonococcal-base broth (Difco Labo-
ratories, Detroit, Mich.) agar plates, characteris-
tic Gram stain and morphology, positive oxidase
reaction, and carbohydrate utilization (glucose
but not maltose) (15). Organisms were frozen at
-70°C until use in tryptic soy broth (Difco
Laboratories, Detroit, Mich.) containing 20%
glycerol (vol/vol).
MICs were determined by a modification of
'the agar dilution method (15). Twofold dilutions
of antibiotic were distributed onto chocolate
agar supplemented with 1% Supplement C
(Difco). Frozen gonococcal isolates were
thawed and grown overnight in antibiotic-free
plates and suspended in GC base broth (Difco)
to an optical density of 25 to 30 Klett units
(Klett-Summerson photoelectric colorimeter),
and ca. 103 CFU were inoculated onto plates
with a Steers replicator. Cultures were incubat-
ed for 24 h at 37°C in a 5% CO2 atmosphere. The
MIC was defined as the lowest concentration of
antimicrobial agent that inhibited visible growth
on the surface of the agar. MIC50 and MIC90
were the lowest concentrations which inhibited
50 and 90%o of tested strains, respectively.
MICs of the antibiotics used are presented in
Tables 1 to 3. Gonococcal strains inhibited by
only 0.5 ,ug or more of penicillin G per ml were
identified as resistant (9). Both beta-lactamase-
positive and -negative penicillin-resistant strains
showed diminished susceptibility to tetracy-
cline, as has been reported previously (9, 12,
14). Beta-lactamase-producing organisms were
100-fold less susceptible and intrinsically resist-
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TABLE 1. Susceptibility of 27 penicillin-susceptible
N. gonorrhoeae isolates to 13 antibiotic agentsa
MIC (4Lgml)
Drug
Range 50o 90% Modal
Penicillin 0.008-0.5 0.03 0.25 0.015
Ampicillin 0.03-0.5 0.06 0.25 0.06
Piperacillin 0.002-0.12 0.008 0.12 0.008
Tetracycline 0.06-2.0 0.25 0.5 0.25
Kanamycin 4.0-50.0 8.0 25.0 8.0
Spectinomycin 16.0-50.0 25.0 50.0 25.0
Cephalexin 0.008-8.0 1.0 4.0 0.5
Cefoxitin 0.12-4.0 0.25 2.0 0.25
Moxalactam 0.002-0.12 0.008 0.06 0.004
Cefoperazone 0.001-0.12 0.008 0.06 0.008
Cefotaxime 0.001-0.06 0.004 0.015 0.002
Ceftazidime 0.008.25 0.015 0.12 0.008
Penem 0.008-0.12 0.03 0.12 0.03
a All isolates were from North Carolina.
ant organisms were 10-fold less susceptible to
piperacillin than were penicillin-sensitive gono-
cocci, consistent with earlier (somewhat con-
flicting) studies .of this agent (1, 6, 16).
All isolates tested were susceptible to spectin-
omycin, cefoxitin, and third-generation cephalo-
sporins, including cefotaxime, cefoperazone,
moxalactam, ceftazidime, and penem. Penicil-
lin-resist%nt isolates generally required some-
what greater concentrations of cephalosporin
than did penicillin-susceptible isolates, although
ceftazidime and penem were only slightly less
active against either penicillinase-producing (Ta-
ble 2) or intrinsically penicillin-resistant isolates
(Table 3) than they were against penicillin-sus-
ceptible isolates (Table 1). Cefotaxime was in-
hibitory at a slightly lower concentration than
either cefoperazone or moxalactam, as reported
TABLE 2. Susceptibility of 10 penicillinase-
producig N. gonorrhoeae isolates to 13 antibiotic
agents'
MIC (4g/mI)
Drug Range 50% 90% Modal
Penicillin >50.0 >50.0 >50.0 >50.0
Ampicillin ;50.0 >50.0 >50.0 >50.0
Piperacillin 1.0->50.0 1.0 25.0 1.0
Tetracycline 0.5-8.0 1.0 8.0 8.0
Kanamycin 16.0-25.0 16.0 25.0 25.0
Spectinomycin 25.0-50.0 50.0 50.0 50.0
Cephalexin 2.0-25.0 4.0 25.0 4.0
Cefoxitin 1.0-4.0 1.0 4.0 1.0
Moxalactam 0.03-0.5 0.06 0.5 0.06
Cefoperazone 0.03-4.0 1.0 2.0 1.0
Cefotaxime 0.004-0.25 0.03 0.12 0.12
Ceftazidime 0.015-0.12 0.03 0.12 0.03
Penem 0.06-0.25 0.12 0.25 0.12
a Four isolates were from North CarolIna, and six
were from the Phillipines.
TABLE 3. Susceptibility of 16 intrinsically
penicillin-resistant (non-penicillinase-producing) N.
gonorrhoeae isolates to 13 antibiotic agents'
MIC (pg/mI)
g Range 50% 90% Modal
Penicillin 1.0-8.0 2.0 4.0 2.0
Ampicillin 0.12-8.0 2.0 4.0 4.0
Piperacillin 0.06-1.0 0.5 1.0 0.5
Tetracycline 0.5-16.0 4.0 8.0 8.0
Kanamycin 16.0-50.0 25.0 50.0 25.0
Spectinomycin 25.0-50.0 25.0 50.0 50.0
Cephalexin 2.0->50.0 16.0 >50.0 16.0
Cefoxitin 1.0-8.0 4.0 8.0 8.0
Moxalactam 0.03-2.0 0.5 1.0 1.0
Cefoperazone 0.06-2.0 0.5 1.0 1.0
Cefotaxime 0.008-.5 0.12 0.5 0.12
Ceftazidime 0.008-0.5 0.12 0.25 0.25
Penem 0.06-0.25 0.12 0.25 0.25
aThirteen isolates were from the Phillipines, and
three were from Denmark.
previously (1, 9). Isolates with intrinsic resist-
ance to penicillin were less susceptible to cefoxi-
tin than were penicillinase-producing strains, as
recently noted by Brown et al. (2). Ceftazidime
was the most effective agent tested against peni-
cillin-resistant isolates. In vitro differences
among newer cephalosporins (e.g., moxalactam,
cefotaxime, ceftazidime, and cefoperazone)
would not be expected to be of clinical signifi-
cance, and initial trials of most of these agents
have been quite successful (D. J. Lancaster,
S. W. Berg, W. 0. Harrison, Program Abstr.
Intersci. Conf. Antimicrob. Agents Chemother.
20th, New Orleans, La., abstr. no. 675,1980; R.
Tight and R. Jones, Program Abstr. Intersci.
Conf. Antimicrob. Agents Chemother. 21st,
Chicago, Ill., abstr. no. 323, 1981; L. J. Straus-
baugh, Program Abstr. Intersci. Conf. Antimi-
crob. Agents Chemother. 21st, Chicago, Ill.,
abstr. no. 483, 1981).
Resistance of gonococci to antibiotics is a
growing problem, particularly because of in-
creasing prevalence of penicillinase-producing
organisms in many parts of the world (1-4, 9,
11-14, 16, 17). Strains which produce penicillin-,
ase may also be intrinsically penicillin resistant
(unpublished data); intrinsic (chromosomal)
resistance is a well recognized problem (2, 4, 5).
In vitro susceptibility to newer cephalosporin
antibiotics of both penicillinase-producing and
intrinsically resistant gonococcal isolates from
diverse regions of the world suggests that effec-
tive therapy for gonorrhoea will be available in
the foreseeable future.
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